Recent federal legislation and newly proposed rules from the U.S. Department of Labor (DOL) are reshaping the pharmacy benefit management (PBM) landscape.

For self-funded employers, these developments are more than policy shifts. They have direct implications for contract terms, fiduciary exposure under ERISA, rebate treatment, pricing transparency, and overall pharmacy benefit strategy.

Regulatory and policy experts will provide a structured overview of newly enacted laws and pending DOL rulemaking, and Jon Koval, PharmD, Vice President, Value Based Pharmacy Care at Transcarent will offer a clinical and market perspective on how these changes may impact plan design, cost management, and Member experience.

In this webinar you will:

1. Get a deeper look at recently enacted PBM legislation and proposed Department of Labor rules that affect ERISA plan sponsors.

2. Examine fiduciary considerations, contractual implications, and compliance risks emerging from new transparency and compensation requirements.

3. Identify practical steps you can take now to mitigate risk, strengthen oversight, and optimize their pharmacy benefit strategy amid regulatory change.